Beinaglutide Shows Significantly Beneficial Effects in Diabetes/Obesity-Induced Nonalcoholic Steatohepatitis in Ob/Ob Mouse Model
The same technique dermatologists use in their clinics for expensive hair restoration treatments
There is a reason for that
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity) work through multiple mechanisms to control blood glucose and reduce appetite
Patients who may particularly benefit from the oral option include: Those with needle concerns: While modern GLP-1 injections use very small needles, some patients have significant needle phobia that prevents them from starting treatment Patients seeking a less medical approach: Some individuals prefer the familiarity of taking a daily pill over self-injecting Weight maintenance candidates: Emerging research suggests oral GLP-1s may be effective for maintaining weight loss after achieving goals on injectable medications Those with access challenges: Pills dont require refrigeration and may be easier to travel with Important Considerations Before Switching or Starting The Wegovy pill will be available in January 2026, with the starting 1.5mg dose priced at $149 per month for cash-paying patients
Preliminary results with retatrutide from TRIUMPH-4 in participants with obesity or overweight and osteoarthritis
